NSC |
Compound |
Enrichment |
Correlation |
NSC 753221 |
3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline |
0.00921214104936179 |
0.40929073 |
NSC 80103 |
2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) |
0.00921214104936179 |
0.55220965 |
NSC 10520 |
Null |
0.00921214104936192 |
-0.081874427 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.00921214104936192 |
0.30615485 |
NSC 287459 |
Cytarabine AY |
0.00921214104936192 |
0.5481073 |
NSC 40665 |
PC 254 |
0.00921214104936192 |
-0.0036571932 |
NSC 659609 |
Null |
0.00921214104936192 |
0.285008 |
NSC 673824 |
Null |
0.00921214104936192 |
0.27050355 |
NSC 127755 |
Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) |
0.00970780973624031 |
0.4666812 |
NSC 133072 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.00970780973624031 |
0.25517965 |